Related references
Note: Only part of the references are listed.Spatiotemporally Targeted Polypeptide Nanoantidotes Improve Chemotherapy Tolerance of Cisplatin
Jiazhen Yang et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2022)
Hyaluronic acid-based nanoplatforms for Doxorubicin: A review of stimuli-responsive carriers, co-delivery and resistance suppression
Milad Ashrafizadeh et al.
CARBOHYDRATE POLYMERS (2021)
Prospective Evaluation of Doxorubicin Cardiotoxicity in Patients with Advanced Soft-tissue Sarcoma Treated in the ANNOUNCE Phase III Randomized Trial
Robin L. Jones et al.
CLINICAL CANCER RESEARCH (2021)
Sequentially stimuli-responsive anticancer nanomedicines
Lingyu Wei et al.
NANOMEDICINE (2021)
Cancer-activated doxorubicin prodrug nanoparticles induce preferential immune response with minimal doxorubicin-related toxicity
Suah Yang et al.
BIOMATERIALS (2021)
Smart transformable nanoparticles for enhanced tumor theranostics
Jinjin Chen et al.
APPLIED PHYSICS REVIEWS (2021)
Co-delivery of IOX1 and doxorubicin for antibody-independent cancer chemo-immunotherapy
Jing Liu et al.
NATURE COMMUNICATIONS (2021)
Lapatinib inhibits doxorubicin induced migration of HER2-positive breast cancer cells
Naveen Chintalaramulu et al.
INFLAMMOPHARMACOLOGY (2020)
Uncoupling DNA damage from chromatin damage to detoxify doxorubicin
Xiaohang Qiao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Carrier-free nanoassembly of doxorubicin prodrug and siRNA for combinationally inducing immunogenic cell death and reversing immunosuppression
Senbiao Chen et al.
NANO TODAY (2020)
Injectable Liquid Crystal Formation System for Reshaping Tumor Immunosuppressive Microenvironment to Boost Antitumor Immunity: Postoperative Chemoimmunotherapy
Mei Hu et al.
SMALL (2020)
Nanostructured Polymeric, Liposomal and Other Materials to Control the Drug Delivery for Cardiovascular Diseases
Dimitrios Skourtis et al.
PHARMACEUTICS (2020)
Fabrication of a pH/Redox-Triggered Mesoporous Silica-Based Nanoparticle with Microfluidics for Anticancer Drugs Doxorubicin and Paclitaxel Codelivery
Jiaqi Yan et al.
ACS APPLIED BIO MATERIALS (2020)
Quick synthesis of a novel combinatorial delivery system of siRNA and doxorubicin for a synergistic anticancer effect
Mengchun Chen et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2019)
Mechanisms of doxorubicin-induced drug resistance and drug resistant tumour growth in a murine breast tumour model
Claudia Christowitz et al.
BMC CANCER (2019)
A Designer Scaffold with Immune Nanoconverters for Reverting Immunosuppression and Enhancing Immune Checkpoint Blockade Therapy
Hathaichanok Phuengkham et al.
ADVANCED MATERIALS (2019)
Enhancing antitumor response by combining immune checkpoint inhibitors with chemotherapy in solid tumors
K. M. Heinhuis et al.
ANNALS OF ONCOLOGY (2019)
Nanomaterial-Based Organelles Protect Normal Cells against Chemotherapy-Induced Cytotoxicity
Ruibo Zhao et al.
ADVANCED MATERIALS (2018)
Nanoparticle formulation improves doxorubicin efficacy by enhancing host antitumor immunity
Eric M. Mastria et al.
JOURNAL OF CONTROLLED RELEASE (2018)
Bottom-up synthesis of carbon nanoparticles with higher doxorubicin efficacy
Samer Bayda et al.
JOURNAL OF CONTROLLED RELEASE (2017)
Tumor Microenvironment Responsive Nanogel for the Combinatorial Antitumor Effect of Chemotherapy and Immunotherapy
Qingle Song et al.
NANO LETTERS (2017)
A review on the efficacy and toxicity of different doxorubicin nanoparticles for targeted therapy in metastatic breast cancer
Ayman Shafei et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
The most prevalent side effects of pegylated liposomal doxorubicin monotherapy in women with metastatic breast cancer: a systematic review of clinical trials
L. Ansari et al.
CANCER GENE THERAPY (2017)
Ultra-small lipid-polymer hybrid nanoparticles for tumor-penetrating drug delivery
Diana Dehaini et al.
NANOSCALE (2016)
Engineered biomimetic nanoabsorbent for cellular detoxification of chemotherapeutics
Tuyen Duong Thanh Nguyen et al.
RSC ADVANCES (2016)
Safe and Immunocompatible Nanocarriers Cloaked in RBC Membranes for Drug Delivery to Treat Solid Tumors
Brian T. Luk et al.
THERANOSTICS (2016)
Long-term intravital imaging of the multicolor-coded tumor microenvironment during combination immunotherapy
Shuhong Qi et al.
ELIFE (2016)
Highly effective antiangiogenesis via magnetic mesoporous silica-based siRNA vehicle targeting the VEGF gene for orthotopic ovarian cancer therapy
Yijie Chen et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2015)
Anti-PD-1/PD-L1 therapy of human cancer: past, present, and future
Lieping Chen et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Highly effective inhibition of lung cancer growth and metastasis by systemic delivery of siRNA via multimodal mesoporous silica-based nanocarrier
Yijie Chen et al.
BIOMATERIALS (2014)
Lipid-insertion enables targeting functionalization of erythrocyte membrane-cloaked nanoparticles
Ronnie H. Fang et al.
NANOSCALE (2013)
Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy
Lionel Apetoh et al.
NATURE MEDICINE (2007)
Dosing time dependency of doxorubicin-induced cardiotoxicity and bone marrow toxicity in rats
H To et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2003)
Share Paper
